Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Suzanne M. Verwijnen"'
Autor:
Eric Brouwer, Maarten ter Horst, Marion de Jong, Suzanne M. Verwijnen, Rob C. Hoeben, Mark Rodijk, Peter A. E. Sillevis Smitt, Bertie de Leeuw
Publikováno v:
Journal of Gene Medicine, 9(12), 1071-1079. John Wiley & Sons Ltd.
Glial fibrillary acidic protein (GFAP) is an intermediate filament protein abundantly expressed in malignant gliomas. We have constructed a novel oncolytic adenovirus, Ad5-gfa2(B)3-E1, for treatment of these tumors. In this construct, the E1 region i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f4f7dc2c15b14da16880d946a9440c
https://doi.org/10.1002/jgm.1110
https://doi.org/10.1002/jgm.1110
Autor:
Astrid Capello, Gerard J. M. van den Aardweg, Eric P. Krenning, Wouter A.P. Breeman, Bert F. Bernard, Marcel de Jong, Mark Konijnenberg, Suzanne M. Verwijnen
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals, 19, 285-292. Mary Ann Liebert Inc.
The rat pancreatic CA20948 tumor cell line is widely used in receptor-targeted preclinical studies because many different peptide receptors are expressed on the cell membrane. The response of the tumor cells to peptide radionuclide therapy, however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f801cf4585410837998febdcd02b5126
https://doi.org/10.1089/1084978041425098
https://doi.org/10.1089/1084978041425098
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals, 23(2), 137-157. Mary Ann Liebert Inc.
Somatostatin receptor-targeting peptides are widely used for the imaging and therapy of neuroendocrine tumors. Peptide-receptor radionuclide therapy (PRRT) in neuroendocrine tumor patients with radiolabeled somatostatin analogs has resulted in sympto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2481396317d535f494b7d8d577e05799
https://pubmed.ncbi.nlm.nih.gov/18454684
https://pubmed.ncbi.nlm.nih.gov/18454684
Autor:
Eric P. Krenning, Suzanne M. Verwijnen, Roelf Valkema, Marion de Jong, Dik J. Kwekkeboom, Monique de Visser
Publikováno v:
Targeted Radionuclide Tumor Therapy ISBN: 9781402086953
Somatostatin receptor-targeting peptides are widely being used for imaging and therapy of neuroendocrine tumors. Peptide receptor radionuclide therapy (PRRT) with e.g. 177Lu labeled somatostatin analogues in neuroendocrine tumor patients has resulted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df35de08ec393605ef45acf03160ec36
https://doi.org/10.1007/978-1-4020-8696-0_7
https://doi.org/10.1007/978-1-4020-8696-0_7
Autor:
Jack L. Erion, Moniaue de Visser, Arnold G. Vulto, Bert F. Bernard, Eric P. Krenning, Marion de Jong, Suzanne M. Verwijnen, Paul J. J. M. Janssen, Wouter A.P. Breeman, Ananth Srinivasan
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 22(3)
Neurotensin (NT) receptors are overexpressed in different human tumors, such as human ductal pancreatic adenocarcinoma. New stable neurotensin analogs with high receptor affinity have been synthesized by replacing arginine residues with lysine and ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef51c1284977ed85c4ee813ccaf19ce
https://pubmed.ncbi.nlm.nih.gov/17651043
https://pubmed.ncbi.nlm.nih.gov/17651043
Autor:
Maarten, ter Horst, Suzanne M, Verwijnen, Eric, Brouwer, Rob C, Hoeben, Marion, de Jong, Bertie H C G M, de Leeuw, Peter A E, Sillevis Smitt
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 47(9)
The overall median survival of patients with a malignant glioma is1 y. Because malignant gliomas rarely metastasize outside the skull, locoregional treatment strategies, such as gene therapy, are under investigation. Recently, convection-enhanced del
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d1b44395ec425bba8ece43f29349e31
https://pubmed.ncbi.nlm.nih.gov/16954557
https://pubmed.ncbi.nlm.nih.gov/16954557
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 46(12)
During tumor therapy with radiolabeled somatostatin analogs, the kidneys are dose limiting. Renal uptake in patients can effectively be reduced by a 4- to 10-h intravenous infusion of a lysine/arginine solution, thereby increasing the maximum radiati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90f3d5e152c6a1714214a492adc5ca54
https://pubmed.ncbi.nlm.nih.gov/16330570
https://pubmed.ncbi.nlm.nih.gov/16330570
Autor:
Leonard I. Wiebe, Akseli Hemminki, Suzanne M. Verwijnen, Marion de Jong, Eric P. Krenning, Rob C. Hoeben, Martin J. W. E. Rabelink, David T. Curiel, Peter A. E. Sillevis Smith
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals, 19(1), 111-120. Mary Ann Liebert Inc.
Patients suffering from malignant glioma have a very poor prognosis. New therapy approaches for gliomas are necessary; these tumors are attractive targets for gene therapy. Our research concentrated on evaluation of the use of the Herpes Simplex Viru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34388b3eee4a4c8762f7e99830f991e
https://pubmed.ncbi.nlm.nih.gov/15068619
https://pubmed.ncbi.nlm.nih.gov/15068619
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals; Apr2008, Vol. 23 Issue 2, p137-157, 21p
Autor:
Paul J.J.M. Janssen, Moniaue de Visser, Suzanne M. Verwijnen, Bert F. Bernard, Ananth Srinivasan, Jack L. Erion, Wouter A.P. Breeman, Arnold G. Vulto, Eric P. Krenning, Marion de Jong
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals; Jun2007, Vol. 22 Issue 3, p374-382, 9p